Skip to main content
Watch Insiders

Corporate insider profile

Mark Schoenberg Insider Trades

Latest reported as Chief Medical Officer of UroGen Pharma Ltd. (URGN).

Purchase filings
0
Reported companies
1
Net open-market value
-$4,084,896.77
Latest transaction
Sep 8, 2026

Affiliated corporations

Reported company relationships

URGNLatest reported

UroGen Pharma Ltd.

Chief Medical Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 8, 2026UroGen Pharma Ltd. (URGN)Chief Medical OfficerSale871$42.92$37,383
Aug 20, 2026UroGen Pharma Ltd. (URGN)Chief Medical OfficerSale60,677$47.05$2,854,853
Jul 9, 2026UroGen Pharma Ltd. (URGN)Chief Medical OfficerSale10,000$40.00$400,000
Jun 22, 2026UroGen Pharma Ltd. (URGN)Chief Medical OfficerSale10,000$35.01$350,100
Jun 8, 2026UroGen Pharma Ltd. (URGN)Chief Medical OfficerSale5,222$27.30$142,561
May 8, 2026UroGen Pharma Ltd. (URGN)Chief Medical OfficerSale10,000$30.00$300,000